//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon
EmailPrint

Registration

Online Registration is Open!
Register by August 15 to Save up to $100 off the standard rates.
» View Pricing

Add to Outlook Calendar

Find Another IBC Event

Cell Therapy Bioprocessing

CSS

Applying the Latest Scientific and Technical Innovations to Build the Bridge from Proof of Concept to Commercialization

September 15-16, 2014 · Sheraton Pentagon City Hotel · Arlington, VA

Conference Partner: International Society for Cellular Therapy (ISCT)

Alt Language

Alternative Language Options:

  • Japanese
  • Korean
  • Taiwanese
  • Chinese
  • English

Event Overview

Event Overview

IBC's Cell Therapy Bioprocessing conference has built a reputation of providing a first-rate faculty of participants, who collectively share perspectives and lessons learned from detailed case studies to help you overcome the challenges, develop the strategies and implement the technologies to propel this field towards commercial sustainability. This meeting continues to serve as a bridge to help companies move their cell therapies from laboratory to commercial scale because this event is committed to establishing cell therapies as a viable and profitable industry.

brochure cover

Brochure Now Available
» Download Today and Receive Free Speaker Interviews!

Keynote Presentations

Developing GMP IPS Lines - Identifying and Eliminating Roadblocks
Mahendra Rao, M.D., Ph.D., Laboratory of Stem Cell Biology Chief, NIH

Impact of Technological Innovations on Cell Therapy Development
Stefan Miltenyi, Managing Director and Founder, Miltenyi Biotec GmbH, Germany

Featured Presentation

World's First Approved Allogeneic Cell Product CARTISTEM®: Two Year Market Update and Global Perspective
Antonio (Tony) Lee, Chief Executive Officer & Managing Director, MEDIPOST America Inc.

"Process innovations in cell therapy are happening at an extremely rapid rate and IBC is the best place to keep up with technology and people in the field." - Jon Rowley, Ph.D., RoosterBio Inc.

Achieve Commercial Success Through Technical and Process Innovations

  • Accelerate Your Therapy to Market by Developing Processes that are Closed, Simple and Rapid
  • Reach Commercial Scale Production by Understanding Key Considerations and Opportunities in Scale Up Manufacturing Processes
  • Remove Bottlenecks for Your Cell Product Candidates by Hearing How Industry Leaders are Developing GMP Technologies
  • Ensure Regulatory Approval by Demonstrating Control of Autologous Cell Therapy Processes Throughout the Validation Lifecycle
  • Reduce Overhead Expenses by Implementing Cost-Effective Standardizing Cryopreservation Techniques

"A great conference for networking and to learn about cell manufacturing challenges. Particularly for new scientists to the field, it gives a great balance of high-level overviews and detailed talks on cell therapies." - Lesley Chan, Ph.D., Development Scientist, Centre for Commercialization of Regenerative Medicine

What Others Say...

"The best commercial manufacturing conference in cell therapy to date. Period!" - Lee Buckler, Cell Therapy Group

"The IBC Cell Therapy conference is an excellent collection of the brightest minds in the cell therapy industry discussing the most critical subjects facing cell therapy today." - Nathan Smith, Mesoblast

"Practical relevant information for companies regardless of clinical phase you are in. Knowledgeable and engaging presenters with great lessons learned and best practices filled the program." - Ellen Colket, Lonza

"The first conference that combined classical bioprocessing tech and industry with academic and clinical fields." - Ricardo Baptista, University of Toronto

"This must-attend forum explores the industry's greatest challenges to develop and manufacture cellular therapies and offers real-world solutions to help you achieve commercial success." - Peter Zandstra, University of Toronto

"This was one of the top bioprocessing meetings last year, and 2012 should be even better. With approval trials advancing in the cell therapy space, requirements for scalable manufacturing positioned to meet COGS and reimbursement targets has growing importance. This creates market opportunity from the bioprocessing industry, whose entry has been long been needed." - Robert J. Deans, Athersys, Inc.

"This year's Cell Therapy Bioprocessing event expands on the foundation that was created at last year's event. It addresses all aspects of cell therapy development, from process issues and product characterization to regulatory concerns. From novices to experienced scientists in this area, there will be something that attendees can learn from the event, and should not be missed!" - Ron Fedechko, Pfizer Inc.

"Cellular bioprocessing is essential to enable scalable and cost effective cell based products to advance into the clinical arena. Anyone from academia or industry interested in an update on state of the art in cellular bioprocessing should consider attending this year's IBC event. A great venue to network and meet key thought leaders in the field." - Jeffrey Karp, Harvard Medical School and Harvard-MIT Division of Health Sciences and Technology

"In order for the entire field to progress, it is imperative that those of us in regenerative medicine participate in discussion forums such as the IBC Cell Therapy conferences in order to move beyond the basic science, and share knowledge (both what works and what does not) that would enable successful clinical commercialization." - Aby J. Mathew, Ph.D., Senior Vice President & Chief Technology Officer, BioLife Solutions, Inc.